4th Microbiome Movement - Drug Development Europe

Date: February 4-6, 2020
Location: London, UK
Link: https://microbiome-europe.com/take-part/register/

DuPont is proud to be part of the 4th Microbiome Movement – Drug Development Europe 2020, which returns to unite leading scientists from the biopharmaceutical and academic community to pursue the causal role of the microbiome in disease, and help create a new generation of microbiome-targeted therapeutics with predictable modes of action and consistent clinical outcomes.

Do not miss the opportunity to hear, Sebastien Guery, Human Microbiome Venture Leader, DuPont Nutrition & Biosciences who will take part in a Panel Discussion: How can Start-Ups Raise Capital to Accelerate Microbiome- Focused Drug Platforms? and a Panel Discussion: The Borderline Between Pharma and Food – How is the Microbiome Blurring the Lines? on February 6.

Register to take part: https://microbiome-europe.com/take-part/register/

Get Started

IFF cares about your privacy. Your personal information (name, email, phone number and other contact data) will be stored in systems primarily hosted in the United States. This information will be used by IFF, its affiliates, partners, and selected service providers in other countries to provide you with the product or service information requested. To learn more, please visit our Privacy Statement.

/content/dupont/amer/us/en/nutrition-biosciences/contact-us.html /content/dupont/amer/us/en/nutrition-biosciences/references/corporate-contact-us.html /content/dupont/amer/us/en/nutrition-biosciences/references/subscribe.html